Piloting Pathways With Lung Cancer Patients
Purpose
The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.
Condition
- Metastatic Lung Cancer
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC - 18 years of age or older - ECOG PS 0-2/Karnofsky 60-100 - 3 to 12 weeks into active cancer treatment
Exclusion Criteria
- unstable brain metastases - cognitive or psychiatric condition for which participating would be inappropriate - unable to speak and read English
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Supportive Care
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Pathways |
Pathways is designed to help patients identify and pursue values-based goals and address potential goal obstacles, including lung cancer stigma. |
|
Recruiting Locations
More Details
- NCT ID
- NCT04161157
- Status
- Completed
- Sponsor
- Laurie McLouth
Detailed Description
In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for advanced stage or metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention.